(Reuters) -Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results, in line with an FDA push to reduce animal testing in the near ...

The FDA is moving away from requiring animal models for investigational new drug (IND) applications for new monoclonal antibodies and some other drug candidates. Animal testing will be "reduced, ...

Sept 2 (Reuters) - Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results, in line with an FDA push to reduce animal testing in ...

Today’s animal testing differs from how it was back in the day. It’s typically done on a specific ingredient rather than a finished product, and there are often regulatory requirements based on ...

The National Institutes of Health announced last week that it will no longer issue funding calls for grant proposals that rely solely on animal testing. Moving forward, all such calls must also ...

In mid-April 2025, a claim spread online that U.S. President Donald Trump's administration had recommitted to ending animal testing at the Environmental Protection Agency (EPA) — an initiative that ...

When we imagine the process of developing new drugs, we often picture scientists working with cutting-edge technology in gleaming laboratories. But there’s a side of pharmaceutical research that is ...

April 10 (UPI) --The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial intelligence, when developing monoclonal antibody therapies and ...

Administrator Lee Zeldin plans to revive a ban on animal testing at the Environmental Protection Agency, The Washington Times has learned. The EPA had pursued a phaseout of animal testing during the ...

Criticism of animal research − usually associated with the progressive left − has grown in recent years, as the practice is blamed for the slow pace of drug development. The Food and Drug ...